Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Precision BioSciences Analyst Ratings and Price Targets | NASDAQ:DTIL | Benzinga
Precision BioSciences Inc has a consensus price target of $23.2 based on the ratings of 6 analysts. The high is $60 issued by HC Wainwright & Co. on May 21, 2025. The low is $1 issued by Goldman Sachs on November 10, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 21, 2025, March 28, 2025, and March 19, 2025, respectively. With an average price target of $60 between HC Wainwright & Co., there's an implied 1117.04% upside for Precision BioSciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
BMO Capital
Guggenheim
BTIG
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Precision BioSciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/21/2025 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2025 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2025 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 02/19/2025 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2025 | Buy Now | 589.66% | BMO Capital | Kostas Biliouris33% | $34 → $34 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/10/2025 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2024 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 04/30/2024 | Buy Now | 285.4% | Guggenheim | Debjit Chattopadhyay54% | → $19 | Initiates | → Buy | Get Alert |
| 04/17/2024 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | Buy Now | 1117.04% | HC Wainwright & Co. | Patrick Trucchio48% | $3 → $60 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | -39.15% | HC Wainwright & Co. | Patrick Trucchio48% | → $3 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2023 | Buy Now | -39.15% | HC Wainwright & Co. | Patrick Trucchio48% | → $3 | Reiterates | Buy → Buy | Get Alert |
| 08/17/2023 | Buy Now | -39.15% | HC Wainwright & Co. | Patrick Trucchio48% | $5 → $3 | Maintains | Buy | Get Alert |
| 08/07/2023 | Buy Now | — | HC Wainwright & Co. | Patrick Trucchio48% | — | Reiterates | → Buy | Get Alert |
| 07/28/2023 | Buy Now | -59.43% | BTIG | Thomas Shrader41% | $6 → $2 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 1.42% | HC Wainwright & Co. | Patrick Trucchio48% | $17 → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/01/2023 | Buy Now | 244.83% | HC Wainwright & Co. | Patrick Trucchio48% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2023 | Buy Now | 244.83% | HC Wainwright & Co. | Patrick Trucchio48% | → $17 | Reiterates | → Buy | Get Alert |
| 03/14/2023 | Buy Now | -18.86% | BMO Capital | Kostas Biliouris33% | $7 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/10/2022 | Buy Now | -79.72% | Goldman Sachs | Salveen Richter54% | $2 → $1 | Maintains | Neutral | Get Alert |
| 11/10/2022 | Buy Now | 244.83% | HC Wainwright & Co. | Patrick Trucchio48% | $20 → $17 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | -59.43% | Goldman Sachs | Salveen Richter54% | $3 → $2 | Maintains | Neutral | Get Alert |
| 06/17/2022 | Buy Now | 41.99% | BMO Capital | Kostas Biliouris33% | → $7 | Initiates | → Outperform | Get Alert |
| 06/09/2022 | Buy Now | — | William Blair | Raju Prasad19% | — | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Precision BioSciences (DTIL) stock?
The latest price target for Precision BioSciences (NASDAQ:DTIL) was reported by HC Wainwright & Co. on May 21, 2025. The analyst firm set a price target for $60.00 expecting DTIL to rise to within 12 months (a possible 1117.04% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Precision BioSciences (DTIL)?
The latest analyst rating for Precision BioSciences (NASDAQ:DTIL) was provided by HC Wainwright & Co., and Precision BioSciences reiterated their buy rating.
When was the last upgrade for Precision BioSciences (DTIL)?
The last upgrade for Precision BioSciences Inc happened on January 10, 2025 when BMO Capital raised their price target to $34. BMO Capital previously had a market perform for Precision BioSciences Inc.
When was the last downgrade for Precision BioSciences (DTIL)?
The last downgrade for Precision BioSciences Inc happened on March 14, 2023 when BMO Capital changed their price target from $7 to $4 for Precision BioSciences Inc.
When is the next analyst rating going to be posted or updated for Precision BioSciences (DTIL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precision BioSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precision BioSciences was filed on May 21, 2025 so you should expect the next rating to be made available sometime around May 21, 2026.
Is the Analyst Rating Precision BioSciences (DTIL) correct?
While ratings are subjective and will change, the latest Precision BioSciences (DTIL) rating was a reiterated with a price target of $60.00 to $60.00. The current price Precision BioSciences (DTIL) is trading at is $4.93, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
